Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
AKTIENPREIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionAgf Management Ltd
Latest Disclosed Ownership81,471 shares
Latest Disclosed Value $ 3,908,164
Agf Management Ltd reports 5.66% increase in ownership of RPD / Royalty Pharma plc

On May 7, 2026 - Agf Management Ltd filed a 13F-HR form disclosing ownership of 81,471 shares of Royalty Pharma plc (DE:RPD) valued at $3,264,543 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 77,106 shares of Royalty Pharma plc. This represents a change in shares of 5.66% during the quarter. The current value of the position is $3,823,027 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Royalty Pharma COM G7709Q104 81,471 4,365 5.66 3,908 31.18 0.0175
2026-02-17 2025-12-31 13F Royalty Pharma COM G7709Q104 77,106 -14,156 -15.51 2,979 -7.46 0.0129
2025-11-04 2025-09-30 13F Royalty Pharma COM G7709Q104 91,262 -1,950 -2.09 3,220 -4.14 0.0142
2025-08-06 2025-06-30 13F Royalty Pharma COM G7709Q104 93,212 12,732 15.82 3,358 34.05 0.0152
2025-05-12 2025-03-31 13F Royalty Pharma COM G7709Q104 80,480 -18,032 -18.30 2,505 -0.32 0.0132
2025-02-07 2024-12-31 13F Royalty Pharma COM G7709Q104 98,512 98,512 2,513 0.0125
2024-08-07 2024-06-30 13F Royalty Pharma COM G7709Q104 0 -16,657 -100.00 0 -100.00
2024-05-13 2024-03-31 13F Royalty Pharma COM G7709Q104 16,657 16,657 506 0.0028
2023-08-09 2023-06-30 13F Royalty Pharma COM G7709Q104 0 -93,508 -100.00 0 -100.00
2023-05-02 2023-03-31 13F Royalty Pharma COM G7709Q104 93,508 14,088 17.74 3,369 7.36 0.0231
2023-02-14 2022-12-31 13F Royalty Pharma COM G7709Q104 79,420 79,420 3,139 0.0228
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.